These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34030964)

  • 21. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.
    Valdez BC; Nieto Y; Yuan B; Murray D; Andersson BS
    Oncotarget; 2022 Oct; 13():1122-1135. PubMed ID: 36243940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells.
    Kanev PB; Varhoshkova S; Georgieva I; Lukarska M; Kirova D; Danovski G; Stoynov S; Aleksandrov R
    Cell Rep; 2024 May; 43(5):114234. PubMed ID: 38758646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.
    Huang D; Kraus WL
    Mol Cell; 2022 Jun; 82(12):2315-2334. PubMed ID: 35271815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
    Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
    Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.
    Rabenau K; Hofstatter E
    Clin Ther; 2016 Jul; 38(7):1577-88. PubMed ID: 27368114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer.
    Liu C; Li J; Xu F; Chen L; Ni M; Wu J; Zhao H; Wu Y; Li J; Wu X; Chen X
    Mol Cancer; 2024 May; 23(1):111. PubMed ID: 38778348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
    Dhakar SS; Galera-Prat A; Lehtiö L
    Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes.
    Yu T; Lok BH
    Expert Rev Anticancer Ther; 2024 Oct; 24(10):989-1008. PubMed ID: 39199000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PARP trapping is governed by the PARP inhibitor dissociation rate constant.
    Gopal AA; Fernandez B; Delano J; Weissleder R; Dubach JM
    Cell Chem Biol; 2024 Jul; 31(7):1373-1382.e10. PubMed ID: 38262416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARP1: Structural insights and pharmacological targets for inhibition.
    Spiegel JO; Van Houten B; Durrant JD
    DNA Repair (Amst); 2021 Jul; 103():103125. PubMed ID: 33940558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer.
    Ma H; Qi G; Han F; Lu W; Peng J; Li R; Yan S; Yuan C; Kong B
    Cell Death Dis; 2022 Mar; 13(3):263. PubMed ID: 35332131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.
    Das C; Dash SR; Sinha S; Paul S; Das B; Bhal S; Sethy C; Kundu CN
    Med Oncol; 2023 Nov; 40(12):351. PubMed ID: 37940725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.
    Ramakrishnan N; Weaver TM; Aubuchon LN; Woldegerima A; Just T; Song K; Vindigni A; Freudenthal BD; Verma P
    Nat Commun; 2024 Jul; 15(1):6343. PubMed ID: 39068174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.
    Verma P; Zhou Y; Cao Z; Deraska PV; Deb M; Arai E; Li W; Shao Y; Puentes L; Li Y; Patankar S; Mach RH; Faryabi RB; Shi J; Greenberg RA
    Nat Cell Biol; 2021 Feb; 23(2):160-171. PubMed ID: 33462394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.
    Meyer-Ficca ML; Lonchar JD; Ihara M; Meistrich ML; Austin CA; Meyer RG
    Biol Reprod; 2011 May; 84(5):900-9. PubMed ID: 21228215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly-ADP ribosylation in DNA damage response and cancer therapy.
    Hou WH; Chen SH; Yu X
    Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ADP-Ribose)-Dependent Chromatin Remodeling in DNA Repair.
    Lebeaupin T; Smith R; Huet S; Timinszky G
    Methods Mol Biol; 2017; 1608():165-183. PubMed ID: 28695510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.